Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Shively

Showing results (431-440 of 458) with videos related to

Pageof 46
Sort By:
The American Journal of Physiology|May 11, 1996
Evidence that CCK-58 has structure that influences its biological activityJ R Reeve, V E Eysselein, G Rosenquist, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignanciesJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2004
Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological propertiesJoseph R Reeve, Rodger A Liddle, Douglas C McVey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancerJ Y Wong, G Somlo, T Odom-Maryon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Tumor Uptake of <sup>64</sup>Cu-DOTA-Trastuzumab in Patients with Metastatic Breast CancerJoanne E Mortimer, James R Bading, Jinha M Park, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Biodistribution of Intra-Arterial and Intravenous Delivery of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Rat Model to Guide Delivery Strategies for Diabetes TherapiesJunfeng Li, Hirotake Komatsu, Erasmus K Poku, et al.
Oncogene|March 21, 2017
CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activationX Ma, Z Meng, L Jin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patientsJ Y Wong, D Z Chu, D Yamauchi, et al.
The Journal of Surgical Research|August 4, 2023
PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse ModelsMichael A Turner, Siamak Amirfakhri, Hiroto Nishino, et al.
Plos One|June 14, 2013
Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencingJinong Feng, Zhifang Zhang, Xiwei Wu, et al.
Pageof 46

Showing results (431-440 of 458) with videos related to

Sort By:
Pageof 46
The American Journal of Physiology|May 11, 1996
Evidence that CCK-58 has structure that influences its biological activityJ R Reeve, V E Eysselein, G Rosenquist, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 19, 2006
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignanciesJeffrey Y C Wong, David Z Chu, Lawrence E Williams, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2004
Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological propertiesJoseph R Reeve, Rodger A Liddle, Douglas C McVey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancerJ Y Wong, G Somlo, T Odom-Maryon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Tumor Uptake of <sup>64</sup>Cu-DOTA-Trastuzumab in Patients with Metastatic Breast CancerJoanne E Mortimer, James R Bading, Jinha M Park, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Biodistribution of Intra-Arterial and Intravenous Delivery of Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles in a Rat Model to Guide Delivery Strategies for Diabetes TherapiesJunfeng Li, Hirotake Komatsu, Erasmus K Poku, et al.
Oncogene|March 21, 2017
CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activationX Ma, Z Meng, L Jin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patientsJ Y Wong, D Z Chu, D Yamauchi, et al.
The Journal of Surgical Research|August 4, 2023
PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse ModelsMichael A Turner, Siamak Amirfakhri, Hiroto Nishino, et al.
Plos One|June 14, 2013
Discovery of potential new gene variants and inflammatory cytokine associations with fibromyalgia syndrome by whole exome sequencingJinong Feng, Zhifang Zhang, Xiwei Wu, et al.
Pageof 46